Center for Cancer Research body css IncludeFiles header footer css http www nci nih gov Link to National Cancer Institute default asp Center for Cancer Research about contact asp Link to Contact CCR default asp Link to CCR Homepage http www nci nih gov Link to NCI home http www nih gov Link to NIH home default asp sidebar css IncludeFiles NewsEvents css news CCR News Desk CCR Press news ooc asp CCR Office of Communication news newsletter asp CCR Frontiers in Science research annual research dir asp Annual Research Directory research manuscript report asp Monthly Manuscript Reports events display default asp Calendar of Events news CCR Press news archive asp Archived CCR News New Genetic Test May Improve Diagnosis of Cervical Dysplasia Researchers from the Genetics Branch Center for Cancer Research and the Hormonal and Epidemiology Branch Division of Cancer Epidemiology and Genetics have developed a new test for detecting a genetic aberration associated with cervical cancer directly in routinely collected patient samples When used in conjunction with standard cytological screening i e the Papanicolaou test the genetic test may improve doctors ability to detect abnormal cervical cells and predict the likelihood that such cells will become cancerous Despite the fact that the Papanicolaou test has greatly reduced the incidence and mortality of cervical cancer in developed countries a single cytological examination is a relatively insensitive and poorly reproducible test that often yields equivocal results Inadequate sampling the scarcity of aberrant cells in premalignant lesions and the subjectivity of evaluating the degree of cellular abnormality all contribute to the known limitations of standard cytological screening Previous studies have shown that extra copies of the long arm of chromosome 3 3q which contains the genetic code for the human telomerase gene are present in at least 80 percent of cervical cancers This genetic alteration is already present in precursor lesions of invasive cervical cancer known as dysplasia However there can be few such genetically abnormal cells in each individual case of dysplasia or cervical cancer An assay capable of identifying these rare cells could provide a useful biomarker for cervical cancer according to the authors of the article published in the October 2003 issue of the American Journal of Pathology Developing a triple color probe set for use with a technique known as fluorescence in situ hybridization FISH to reveal cells containing extra copies of 3q the researchers analyzed 57 slides that had been rigorously screened and classified as normal atypical low grade squamous intraepithelial lesions LSIL or high grade squamous intraepithelial lesions HSIL The results of the blinded study showed that only a few of the samples categorized as normal atypical and LSIL harbored multiple copies of 3q compared to 63 percent to 76 percent of grade 2 and grade 3 HSIL specimens respectively The scientists concluded that testing routinely prepared slides for extra copies of 3q in this way is a valuable independent screening tool for HSIL and may help to determine the progressive potential of individual precancerous lesions While studies have shown that about 80 percent of LSIL samples test positive for cancer related human papilloma virus types only one out of 14 LSIL specimens in this study had multiple 3q copies as detected by the FISH assay Therefore the value of the FISH assay has great potential as a sensitive and also highly specific test for identifying women with LSIL who harbor HSIL or are destined to progress These results combined with the availability of new computer imaging and analysis programs provide the rationale and the tools for further exploration of the diagnostic and predictive power of this genetic marker in cervical cytology Heselmeyer Haddad K Janz V Castle P E Chaudhri N White N Wilber K Morrison L E Auer G Burroughs F H Sherman M E and Ried T Detection of Genomic Amplification of the Human Telomerase Gene TERC in Cytological Specimens as a Genetic Test for the Diagnosis of Cervical Dysplasia American Journal of Pathology Vol 163 No 4 October 2003 IncludeFiles header footer css http www nih gov Link to NIH default asp CCR Home http ccr nci nih gov trials about About CCR trials Clinical Trials research Research careers Employment initiatives Featured Initiatives news News events Events http www1 od nih gov oitnew2 privacy html Site Privacy Policy about accessibility asp Accessibility 2000 2001 Center for Cancer Research at the National Cancer Institute http www firstgov gov Link to FirstGov
